Company: AIZ
Filing Date: 2025-08-15
Form Type: 424B5
Source: 0001193125-25-181851
Chunk: 26

Company: ASSURANT, INC.
Filing Date: 2025-08-15
Form: 424B5
Chunk 26
---
 the requirements of Title I of ERISA or Section 4975 of the Code, they may be subject to similar provisions under applicable federal, state, local, non-U.S. or other laws

S-19

or regulations (“Similar Laws”). Fiduciaries of Other Plan Arrangements should consult with their counsel regarding the potential consequences of an investment in the Notes under any
applicable Similar Laws before acquiring the Notes.

Representation

Each purchaser or holder of Notes or any interest therein represents by its purchase, holding and disposition of Notes that either (1) it
is not a Plan or Other Plan Arrangement and it is not purchasing or holding the Notes on behalf of or with the assets of any Plan or Other Plan Arrangement, or (2) its purchase, holding and disposition of the Notes will not constitute or result
in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or a violation under any applicable Similar Laws.

Purchasers of Notes have exclusive responsibility for ensuring that their purchase and holding of Notes do not violate the fiduciary
responsibility or prohibited transaction rules of Title I of ERISA or Section 4975 of the Code or any provisions of applicable Similar Laws. The sale of any Notes to a Covered Plan or Other Plan Arrangement is in no respect a representation by
us, the underwriters or any of our or their affiliates or representatives that such an investment meets all relevant legal requirements with respect to investments by any such Covered Plans or Other Plan Arrangements generally or any particular
Covered Plan or Other Plan Arrangement or that such investment is appropriate for such Covered Plans or Other Plan Arrangements generally or any particular Covered Plan or Other Plan Arrangement. Neither this discussion nor anything provided in this
prospectus supplement is or is intended to be investment advice directed at any potential benefit plan investor or at benefit plan investors generally and such purchasers should consult and rely on their own counsel and advisors as to whether an
investment in the Notes is suitable.

S-20

UNDERWRITING Barclays Capital Inc. and Goldman Sachs & Co. LLC are acting as joint book-running managers of the offering and as representatives of the underwriters named below. Subject to the terms and conditions stated in the underwriting agreement dated the date of this prospectus supplement, each underwriter named below has severally agreed to purchase, and we have agreed to sell to that underwriter, the principal amount of Notes set forth opposite the underwriter’s name.

| Under